Olema Pharmaceuticals, Inc.
OLMA
$4.42
$0.163.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 65.80% | -22.44% | 42.80% | 33.89% | 28.07% |
| Total Receivables | 215.01% | -7.16% | 31.99% | 119.87% | 110.97% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -19.18% | 44.90% | 51.41% | 8.55% | -11.01% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -78.23% | -93.14% | -91.71% | -83.11% | 10.88% |
| Total Current Assets | 64.52% | -22.70% | 41.21% | 33.10% | 27.58% |
|
|
|||||
| Total Current Assets | 64.52% | -22.70% | 41.21% | 33.10% | 27.58% |
| Net Property, Plant & Equipment | -36.79% | -33.15% | -14.08% | -14.22% | 30.62% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 45.63% | 36.03% | 230.96% | 207.33% | 68.74% |
| Total Assets | 62.84% | -21.39% | 43.31% | 34.70% | 28.43% |
|
|
|||||
| Total Accounts Payable | 65.31% | 21.66% | 167.94% | 1,024.23% | 621.39% |
| Total Accrued Expenses | 102.02% | 109.78% | 70.63% | -1.65% | 18.35% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 18.62% | 23.05% | 38.22% | 16.41% | -2.66% |
| Total Finance Division Other Current Liabilities | -43.84% | 26.32% | -32.97% | -16.51% | 7.35% |
| Total Other Current Liabilities | -43.84% | 26.32% | -32.97% | -16.51% | 7.35% |
| Total Current Liabilities | 93.14% | 92.28% | 78.92% | 35.11% | 30.65% |
|
|
|||||
| Total Current Liabilities | 93.14% | 92.28% | 78.92% | 35.11% | 30.65% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -82.02% | -66.92% | -29.01% | -16.70% | -7.81% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 82.28% | 76.97% | 70.77% | 31.66% | 27.36% |
|
|
|||||
| Common Stock & APIC | 50.92% | 8.25% | 41.67% | 38.65% | 36.94% |
| Retained Earnings | -42.36% | -43.99% | -42.60% | -41.87% | -46.25% |
| Treasury Stock & Other | -58.79% | 292.53% | 77.22% | 98.98% | 119.14% |
| Total Common Equity | 61.08% | -27.70% | 40.59% | 35.06% | 28.52% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 61.08% | -27.70% | 40.59% | 35.06% | 28.52% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 61.08% | -27.70% | 40.59% | 35.06% | 28.52% |
|
|
|||||